Hepamerz%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252528l-Ornithine%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520l-Aspartate%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520-%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520lola%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252529

# Hepamerz (L-Ornithine L-Aspartate) ## Overview Hepamerz is a combination of the amino acids L-ornithine and L-aspartate. It is thought to reduce ammonia levels in the blood by promoting its detoxification in the liver and kidneys. ## Primary Indications Treatment of latent and overt hepatic encephalopathy in patients with hyperammonemia. ## Adult Dosing * **Oral:** 3 sachets (18 g total) per day, divided into 3 doses. * **Intravenous (IV):** Typically 10-20 g once daily, administered as an infusion over 30-60 minutes. Specific dosing and duration depend on the severity of encephalopathy and patient response. Dosing may be guided by local protocols. ## Pediatric Dosing There is limited pediatric data. Use should be guided by expert clinical judgment and may require individualized dosing. ## Dose Adjustments No specific dose adjustments are typically required for renal or hepatic impairment, as the drug is metabolized by the body. However, caution is advised in patients with severe renal impairment due to potential accumulation of the amino acids. ## Contraindications * Hypersensitivity to L-ornithine L-aspartate or any component of the formulation. * Severe renal insufficiency (creatinine clearance < 25 mL/min) or patients with pre-existing metabolic disorders of amino acid metabolism. ## Adverse Effects Common adverse effects include nausea, vomiting, abdominal discomfort, and diarrhea. Less common effects include headache and dizziness. ## Key Drug Interactions No significant drug interactions have been definitively established. ## Monitoring * Monitor ammonia levels. * Assess neurological status for improvement or signs of worsening hepatic encephalopathy. * Monitor renal function. ## Clinical Pearls * The oral formulation can be mixed with water, juice, or tea. * Treatment duration varies; it can be used for acute episodes or long-term management. * Efficacy is generally observed when ammonia levels are elevated. **Disclaimer:** Always consult the most current prescribing information and relevant clinical guidelines for definitive dosing and management. This information is not a substitute for professional medical advice.